Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-25

FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (SpecGx LLC)

View source ↗

Summary

FDA approved lisdexamfetamine dimesylate under an Original Application (generic) filed by SpecGx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)